Difference between revisions of "Pirarubicin (THP)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | '' | + | ''Approved for use in a number of countries; not the US.'' |
| − | |||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Bladder cancer]] | *[[Bladder cancer]] | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Code name:''' 1609-RB | ||
| + | *'''Generic name:''' theprubicin, THP-doxorubicin | ||
| + | *'''Brand names:''' Pinorubicin, Pinorubin, Therarubicin | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
| − | [[Category: | + | [[Category:Intravenous chemotherapy]] |
| + | |||
[[Category:Anthracyclines]] | [[Category:Anthracyclines]] | ||
Revision as of 03:20, 19 August 2017
Approved for use in a number of countries; not the US.
Diseases for which it is used
Also known as
- Code name: 1609-RB
- Generic name: theprubicin, THP-doxorubicin
- Brand names: Pinorubicin, Pinorubin, Therarubicin